The reagent kit is used in the examination of patients diagnosed with colorectal cancer to determine indications for targeted therapy.
Reagent kits cannot be used to diagnose any pathology and are intended only for qualitative determination of the NRAS gene mutation status to determine indications for targeted therapy.